{"created":"2023-06-19T07:26:13.232212+00:00","id":14569,"links":{},"metadata":{"_buckets":{"deposit":"226242a3-22d3-4eb5-b9d1-e00a07a7b6dc"},"_deposit":{"created_by":124,"id":"14569","owners":[124],"pid":{"revision_id":0,"type":"depid","value":"14569"},"status":"published"},"_oai":{"id":"oai:gifu-pu.repo.nii.ac.jp:00014569","sets":["212:260"]},"author_link":["34784","34776","34781","34782","34786","34774","34788","34791","34783","34775","34780","34785","34789","34790","34787","34778","34773","34779","34777"],"item_3_biblio_info_3":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2021","bibliographicIssueDateType":"Issued"},"bibliographicPageEnd":"54","bibliographicPageStart":"49","bibliographicVolumeNumber":"161","bibliographic_titles":[{},{"bibliographic_title":"Lung cancer (Amsterdam, Netherlands)","bibliographic_titleLang":"en"}]}]},"item_3_text_4":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_text_value":"10.1016/j.lungcan.2021.08.007"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"Adult","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Afatinib","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Aged","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Aged, 80 and over","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Carcinoma, Non-Small-Cell Lung","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"ErbB Receptors","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Female","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Humans","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Lung Neoplasms","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Middle Aged","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Mutation","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Prospective Studies","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Protein Kinase Inhibitors","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Treatment Outcome","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"A prospective, phase II trial of monotherapy with low-dose afatinib for patients with EGFR, mutation-positive, non-small cell lung cancer: Thoracic oncology research group 1632.","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"A prospective, phase II trial of monotherapy with low-dose afatinib for patients with EGFR, mutation-positive, non-small cell lung cancer: Thoracic oncology research group 1632.","subitem_title_language":"en"}]},"item_type_id":"3","owner":"124","path":["260"],"pubdate":{"attribute_name":"公開日","attribute_value":"2022-03-08"},"publish_date":"2022-03-08","publish_status":"0","recid":"14569","relation_version_is_last":true,"title":["A prospective, phase II trial of monotherapy with low-dose afatinib for patients with EGFR, mutation-positive, non-small cell lung cancer: Thoracic oncology research group 1632."],"weko_creator_id":"124","weko_shared_id":-1},"updated":"2023-06-19T07:41:44.158902+00:00"}